Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma

BACKGROUND: The prognosis of metastatic clear cell renal cell carcinoma (ccRCC) vastly improved since the introduction of antiangiogenic-targeted therapy. However, it is still unclear which biological processes underlie ccRCC aggressiveness and affect prognosis. Here, we checked whether a recently d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatto, Francesco, Maruzzo, Marco, Magro, Cristina, Basso, Umberto, Nielsen, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121125/
https://www.ncbi.nlm.nih.gov/pubmed/27933273
http://dx.doi.org/10.3389/fonc.2016.00253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121125/
https://www.ncbi.nlm.nih.gov/pubmed/27933273
http://dx.doi.org/10.3389/fonc.2016.00253

Ejemplares similares